Future Science OA最新文献

筛选
英文 中文
Hematological, inflammatory and serological responses among COVID-19 patients admitted to intensive care unit. 入住重症监护室的 COVID-19 患者的血液学、炎症和血清学反应。
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-08-22 DOI: 10.1080/20565623.2024.2389664
Mirette A Morgan, Sarra E Saleh, Azza H Salamoni, Mohammad Y Alshahrani, Khaled M Aboshanab
{"title":"Hematological, inflammatory and serological responses among COVID-19 patients admitted to intensive care unit.","authors":"Mirette A Morgan, Sarra E Saleh, Azza H Salamoni, Mohammad Y Alshahrani, Khaled M Aboshanab","doi":"10.1080/20565623.2024.2389664","DOIUrl":"10.1080/20565623.2024.2389664","url":null,"abstract":"<p><p><b>Aim:</b> To correlate hematological, inflammatory indicators and serological responses among COVID-19 patients to point out the significant biomarkers for disease management and prognosis.<b>Materials & methods:</b> Standard analytical and molecular methods were used to assess various inflammatory and serological Responses among COVID-19 patients (ICU- (n = 99) and non-ICU patients (n = 64) as compared with health control (n = 40).<b>Results:</b> Significant differences in the Hb, WBC, Lymphocyte count, CRP and serum ferritin (<i>p</i> < 0.05) were observed. Patients' IgM/IgG antibodies against SARS-CoV-2 were associated with increased CRP, LDH and serum ferritin levels.<b>Conclusion:</b> A significant association between serum IgG/IgM and ICU admission was observed. Although serum ferritin and LDH can offer information about the extent of inflammation, they are exclusive factors for ICU admission.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2389664"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11346553/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the impact of testosterone replacement therapy on carotid atherosclerosis: a systematic review and meta-analysis. 评估睾酮替代疗法对颈动脉粥样硬化的影响:系统回顾和荟萃分析。
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-08-25 DOI: 10.1080/20565623.2024.2365125
Syed Hamza Haider, Areeka Irfan, Samir Mustafa Sheikh, Muhammad Taha Abid, Turba Naz, Mudassir Abbas, Alishba Raza
{"title":"Evaluating the impact of testosterone replacement therapy on carotid atherosclerosis: a systematic review and meta-analysis.","authors":"Syed Hamza Haider, Areeka Irfan, Samir Mustafa Sheikh, Muhammad Taha Abid, Turba Naz, Mudassir Abbas, Alishba Raza","doi":"10.1080/20565623.2024.2365125","DOIUrl":"10.1080/20565623.2024.2365125","url":null,"abstract":"<p><p><b>Aim:</b> This meta-analysis investigates the association between testosterone replacement therapy [TRT] and carotid artery atherosclerosis. <b>Methods:</b> 3 databases were searched for studies up to June 2023 per the PRISMA guidelines. The eligibility criteria comprised RCTs and observational studies involving hypogonadal males receiving exogenous testosterone, in which CIMT was assessed. CAA was the primary outcome, whereas secondary outcomes included HDL, LDL, CRP, total cholesterol and total testosterone. The statistical analysis was performed using Review Manager. <b>Results:</b> Statistical analysis revealed no association between TRT and assessed outcomes. There was a significant increase in total testosterone levels, depicting indirect anti-atherosclerotic effects of TRT. <b>Conclusion:</b> Meta-analysis shows no relation between TRT and CIMT or other markers, allowing its safe usage for hypogonadal males.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2365125"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11352792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142055359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis. 基于生物信息学和荟萃分析的 PSMD14 在癌症中的临床病理和预后意义。
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-10-11 DOI: 10.1080/20565623.2024.2409054
Shu-Yi Dong, Shuxin Ding, Zhen Meng, Bo Zou
{"title":"The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis.","authors":"Shu-Yi Dong, Shuxin Ding, Zhen Meng, Bo Zou","doi":"10.1080/20565623.2024.2409054","DOIUrl":"10.1080/20565623.2024.2409054","url":null,"abstract":"<p><p><b>Aim:</b> To evaluate the clinic-pathological features and prognostic value regarding PSMD14 in cancers.<b>Materials & methods:</b> Literature was gathered from public databases until 22 June 2023 to analyze data on survival rates and clinicopathological characteristics associated with PSMD14. TCGA and GEO data were also utilized for validation.<b>Results:</b> Eight reports on seven types of tumors showed that high PSMD14 expression was linked to poorer overall survival and disease-free survival. PSMD14 expression also correlated with larger tumor size, differentiation and metastasis, as well as the effectiveness of various chemotherapy drugs.<b>Conclusion:</b> PSMD14 could serve as a potential biomarker of poor prognosis in cancers, including lung cancer, head and neck squamous cell carcinoma, ovarian cancer, breast cancer and hepatocellular carcinoma.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2409054"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11486200/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142399975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical treatment strategy and follow-up of lymphoepithelioma-like carcinoma: a retrospective study. 淋巴上皮瘤样癌的临床治疗策略和随访:一项回顾性研究。
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-08-30 DOI: 10.1080/20565623.2024.2384878
Shilong Zhang, Yufu Lin, Zhiyong Li, Zhiming Wang, Rongkui Luo, Xiuping Zhang
{"title":"Clinical treatment strategy and follow-up of lymphoepithelioma-like carcinoma: a retrospective study.","authors":"Shilong Zhang, Yufu Lin, Zhiyong Li, Zhiming Wang, Rongkui Luo, Xiuping Zhang","doi":"10.1080/20565623.2024.2384878","DOIUrl":"10.1080/20565623.2024.2384878","url":null,"abstract":"<p><p><b>Aim:</b> To investigate the clinical features, diagnosis and treatment of lymphoepithelioma-like carcinoma (LELC).<b>Materials & methods:</b> The clinical data of 114 LELC patients were retrospectively analyzed.<b>Results:</b> Ninety-eight patients (86.0%) were Epstein-Barr virus-encoded small RNA (EBER) positive detected by situ hybridization. A 67.1% (51/76) patients had PD-L1 expression. The 5-year overall survival rate of EBER negative patients was 51.6% while the rate of positive patients was 84.8% (<i>p</i> = 0.015). The 5-year progression free survival rate of EBER negative patients was 40.2% while the rate of positive patients was 70.2% (<i>p</i> = 0.004).<b>Conclusion:</b> The progression of LELC is relatively slow and present a better prognosis. The occurrence of tumor is closely related to Epstein-Barr virus infection and PD-L1 is highly expressed in tumor cells.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2384878"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11385158/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142106382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation and characterization of antibiotic drug loaded aquasome for the topical application. 用于局部应用的抗生素药物负载 aquasome 的制备和表征。
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-07-09 DOI: 10.1080/20565623.2024.2367849
Bhuvaneshwari Shanmugam, Umashankar Marakanam Srinivasan
{"title":"Formulation and characterization of antibiotic drug loaded aquasome for the topical application.","authors":"Bhuvaneshwari Shanmugam, Umashankar Marakanam Srinivasan","doi":"10.1080/20565623.2024.2367849","DOIUrl":"10.1080/20565623.2024.2367849","url":null,"abstract":"<p><p><b>Aim:</b> This study aimed to develop a topical antibiotic drug delivery system using aquasomes for enhanced treatment of skin and soft tissue infections (SSTIs). <b>Materials & methods:</b> Cephalothin was loaded into aquasomes using a multi-step process and optimized using design of experiment. The aquasomes were characterized for FT-IR, SEM and zeta potential analysis. Entrapment efficacy, <i>In vitro</i> drug release studies, antibacterial assays and stability study was performed to evaluate the efficacy of the formulated aquasomes. <b>Results & conclusion:</b> The formulated cephalothin-loaded aquasomes exhibited stable properties, controlled drug release and significant antibacterial activity against bacteria. This proves that the developed aquasome-based delivery system has the potential for sustained treatment of SSTIs.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2367849"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11238917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141563146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A consultation and work-up diagnosis protocol for a multicancer early detection test: a case series study. 多癌早期检测的咨询和工作诊断方案:病例系列研究。
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-09-10 DOI: 10.1080/20565623.2024.2395244
Luu Hong Dang Nguyen, Ba Linh Tieu, Thi Thanh Nguyen, Nhung Phuong Ha, Giang Thi Huong Nguyen, Thi Hue Hanh Nguyen, Van Hoi Le, Vinh Quang Bui, Lan Hieu Nguyen, Nhu Hiep Pham, Thanh Hai Phan, Huu Thinh Nguyen, Van Song Tran, Chi Viet Bui, Van Kha Vo, Pham Thanh Nhan Nguyen, Ha Huu Phuoc Dang, Van Dung Pham, Van Thinh Cao, Ngoc Minh Phan, Van Tung Nguyen, Thi Le Quyen Le, Thi Lan-Anh Luong, Thi Kim Phuong Doan, Canh Duy Phan, Thanh Xuan Nguyen, Nguyen Tuong Pham, Bao Toan Nguyen, Thi Thu Thuy Pham, Huu Linh Le, Cong Thanh Truong, Thanh Xuan Jasmine, Minh Chi Le, Van Bau Phan, Quang Binh Truong, Thi Huong Ly Tran, Minh Thien Huynh, Tu Quy Tran, Si Tuan Nguyen, Vu Tran, Van Khanh Tran, Huu Nguyen Nguyen, Thi Van Phan, Thi Thanh-Thuy Do, Dinh Kiet Truong, Hoa Giang, Hoai-Nghia Nguyen, Minh-Duy Phan, Le Son Tran, Hung Sang Tang, Duy Sinh Nguyen
{"title":"A consultation and work-up diagnosis protocol for a multicancer early detection test: a case series study.","authors":"Luu Hong Dang Nguyen, Ba Linh Tieu, Thi Thanh Nguyen, Nhung Phuong Ha, Giang Thi Huong Nguyen, Thi Hue Hanh Nguyen, Van Hoi Le, Vinh Quang Bui, Lan Hieu Nguyen, Nhu Hiep Pham, Thanh Hai Phan, Huu Thinh Nguyen, Van Song Tran, Chi Viet Bui, Van Kha Vo, Pham Thanh Nhan Nguyen, Ha Huu Phuoc Dang, Van Dung Pham, Van Thinh Cao, Ngoc Minh Phan, Van Tung Nguyen, Thi Le Quyen Le, Thi Lan-Anh Luong, Thi Kim Phuong Doan, Canh Duy Phan, Thanh Xuan Nguyen, Nguyen Tuong Pham, Bao Toan Nguyen, Thi Thu Thuy Pham, Huu Linh Le, Cong Thanh Truong, Thanh Xuan Jasmine, Minh Chi Le, Van Bau Phan, Quang Binh Truong, Thi Huong Ly Tran, Minh Thien Huynh, Tu Quy Tran, Si Tuan Nguyen, Vu Tran, Van Khanh Tran, Huu Nguyen Nguyen, Thi Van Phan, Thi Thanh-Thuy Do, Dinh Kiet Truong, Hoa Giang, Hoai-Nghia Nguyen, Minh-Duy Phan, Le Son Tran, Hung Sang Tang, Duy Sinh Nguyen","doi":"10.1080/20565623.2024.2395244","DOIUrl":"https://doi.org/10.1080/20565623.2024.2395244","url":null,"abstract":"<p><p>The emergence of multicancer early detection (MCED) tests holds promise for improving early cancer detection and public health outcomes. However, positive MCED test results require confirmation through recommended cancer diagnostic imaging modalities. To address these challenges, we have developed a consultation and work-up protocol for definitive diagnostic results post MCED testing, named SPOT-MAS. Developed through circulating tumor DNA (ctDNA) analysis and in line with professional guidelines and advisory board consensus, this protocol standardizes information to aid general practitioners in accessing, interpreting and managing SPOT-MAS results. Clinical effectiveness is demonstrated through a series of identified cancer cases. Our research indicates that the protocol could empower healthcare professionals to confidently interpret circulating tumor DNA test results for 5 common types of cancer, thereby facilitating the clinical integration of MCED tests.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2395244"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11389743/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142283896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A computational study of gene expression patterns in head and neck squamous cell carcinoma using TCGA data. 利用 TCGA 数据对头颈部鳞状细胞癌的基因表达模式进行计算研究。
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-08-14 DOI: 10.1080/20565623.2024.2380590
Saqib Rauf, Sami Ullah, Muhammad Adil Abid, Asad Ullah, Gullzar Khan, Ainee Urooj Khan, Gulzar Ahmad, Muhammad Ijaz, Sidra Ahmad, Sulaiman Faisal
{"title":"A computational study of gene expression patterns in head and neck squamous cell carcinoma using TCGA data.","authors":"Saqib Rauf, Sami Ullah, Muhammad Adil Abid, Asad Ullah, Gullzar Khan, Ainee Urooj Khan, Gulzar Ahmad, Muhammad Ijaz, Sidra Ahmad, Sulaiman Faisal","doi":"10.1080/20565623.2024.2380590","DOIUrl":"10.1080/20565623.2024.2380590","url":null,"abstract":"<p><p><b>Aim:</b> Head and Neck squamous cell carcinoma (HNSCC) is the second most prevalent cancer in Pakistan. <b>Methods:</b> Gene expression data from TCGA and GETx for normal genes to analyze Differentially Expressed Genes (DEGs). Data was further investigated using the Enrichr tool to perform Gene Ontology (GO). <b>Results:</b> Our analysis identified most significantly differentially expressed genes and explored their established cellular functions as well as their potential involvement in tumor development. We found that the highly expressed Keratin family and <i>S100A9</i> genes. The under-expressed genes <i>KRT4</i> and <i>KRT13</i> provide instructions for the production of keratin proteins. <b>Conclusion:</b> Our study suggests that factors such as poor oral hygiene and smokeless tobacco can result in oral stress and cellular damage and cause cancer.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2380590"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11326450/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Green synthesized Zingiber officinale-ZnO nanoparticles: anticancer efficacy against 3D breast cancer model. 绿色合成的银杏叶-氧化锌纳米粒子:对三维乳腺癌模型的抗癌功效
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-11-14 DOI: 10.1080/20565623.2024.2419806
Ruqaya Alhaddad, Bassam M Abualsoud, Ibrahim Al-Deeb, Hamdi Nsairat
{"title":"Green synthesized <i>Zingiber officinale</i>-ZnO nanoparticles: anticancer efficacy against 3D breast cancer model.","authors":"Ruqaya Alhaddad, Bassam M Abualsoud, Ibrahim Al-Deeb, Hamdi Nsairat","doi":"10.1080/20565623.2024.2419806","DOIUrl":"10.1080/20565623.2024.2419806","url":null,"abstract":"<p><p><b>Aim:</b> ZnO NPs were prepared via green synthesis utilizing <i>Zingiber Officinale</i>.<b>Methodology:</b> Physical characterization and biological activity were performed against 2D, and 3D spheroids MCF-7 cell lines.<b>Results:</b> The NPs exhibited 188.9, 175.7 and 171.2 nm size with charge of -8.2, -11.7 and -9.7 mV for the 2%, 3% and 4% formulations. XRD confirmed a wurtzite hexagonal phase. FTIR spectra showed Zn-O stretching vibrations. The 2%, 3% and 4% formulations presented IC<sub>50</sub> values of 14.7, 26.2 and 47 μg/ml, respectively, with complete destruction of MCF-7 spheroids. Elevated <i>TNF-α</i> levels suggested an inflammatory-mediated mechanism of action.<b>Conclusion:</b> 2% <i>Zingiber officinale</i>-derived ZnO NPs showed antitumor potential against deserving further mechanistic and <i>in vivo</i> explorations.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2419806"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572278/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The United Nations' ambitious roadmap against tuberculosis: opportunities, challenges and the imperative of equity. 联合国防治结核病的宏伟路线图:机遇、挑战和公平的必要性。
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-11-14 DOI: 10.1080/20565623.2024.2418787
Bashar Haruna Gulumbe, Abdulrakib Abdulrahim, Mohammed Bashar Danlami
{"title":"The United Nations' ambitious roadmap against tuberculosis: opportunities, challenges and the imperative of equity.","authors":"Bashar Haruna Gulumbe, Abdulrakib Abdulrahim, Mohammed Bashar Danlami","doi":"10.1080/20565623.2024.2418787","DOIUrl":"10.1080/20565623.2024.2418787","url":null,"abstract":"","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2418787"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572144/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors influencing brain recovery from stroke via possible epigenetic changes. 通过可能的表观遗传变化影响中风后大脑恢复的因素。
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-10-21 DOI: 10.1080/20565623.2024.2409609
Orjon Rroji, Carla Mucignat
{"title":"Factors influencing brain recovery from stroke via possible epigenetic changes.","authors":"Orjon Rroji, Carla Mucignat","doi":"10.1080/20565623.2024.2409609","DOIUrl":"10.1080/20565623.2024.2409609","url":null,"abstract":"<p><p><b>Aim:</b> To examine epigenetic changes leading to functional repair after damage to the central motor system.<b>Data sources:</b> A literature search was conducted using medical and health science electronic databases (PubMed, MEDLINE, Scopus) up to July 2023.<b>Study selection:</b> Data were summarized for type of intervention, study design, findings including human and animal studies.<b>Data extraction:</b> Data were extracted and double-checked independently for methodological quality. By means of the influence of environmental (calorie restriction or physical exercise) and other factors, epigenetic instructions were found to increase levels of <i>BDNF</i> and enhance synaptic neurotransmission, possibly leading to larger scale changes in structural and functional assets, which may end up to cognitive and motor repair after stroke.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2409609"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11497982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142462782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信